MLYS
Mineralys Therapeutics Inc.
Company Overview
| Mkt Cap | $2.70B | Price | $40.86 |
| Volume | 1.05M | Change | -0.63% |
| P/E Ratio | -15.2 | Open | $40.80 |
| Revenue | -- | Prev Close | $41.12 |
| Net Income | $-177.8M | 52W Range | $8.24 - $44.80 |
| Div Yield | N/A | Target | $43.75 |
| Overall | 61 | Value | 60 |
| Quality | 42 | Technical | 83 |
No chart data available
Stock Overview
Updated DailyMineralys Therapeutics Inc. (MLYS) is a leading diversified company in the business industry, currently trading at $40.86 with a market capitalization of $2.70 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating below-average quality metrics with a MarketXLS quality score of 42.
Today's trading session shows MLYS with a volume of 1.05 million shares. The stock opened down 0.78% from yesterday's close of $41.12. Current analyst estimates project earnings of $-2.95 per share for this year, with next year targeting $-3.06.
MLYS demonstrates very strong technical momentum based on technical analysis. The company trades on the NGS exchange.
Key investment considerations for MLYS include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 7.1%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 07:25 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MLYS | $40.86 | -0.6% | 1.05M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Mineralys Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW